1. Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment
   George S. Stoyanov et al, 2018, Medical Oncology CrossRef
2. Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
   Aglaia Schiza et al, 2022, European Journal of Cancer CrossRef
3. Breast cancer subtype and clinical characteristics in women from Peru
   Valentina A. Zavala et al, 2023, Frontiers in Oncology CrossRef
4. Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysis
   Gabriel De-la-Cruz-Ku et al, 2020, Breast Disease CrossRef
5. Targeted Antitumor Drug Delivery to Glioblastoma Multiforme Cells
   T. I. Shlapakova et al, 2021, Russian Journal of Bioorganic Chemistry CrossRef
6. Neoadjuvant pertuzumab in non‑metastatic HER2‑positive breast tumors: Multicentric study in Peru (NeoHer)
   Silvia Falcon et al, 2022, Molecular and Clinical Oncology CrossRef
7. Analysis on status quo and related factors of delays in diagnosis and treatment of breast cancer in Ningxia Hui Autonomous Region
   Yuchen Wang et al, 2024, Medicine CrossRef
8. The hispanic landscape of triple negative breast cancer
   Alejandra Zevallos et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
9. Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer
   Zaida Morante et al, 2021, Clinical Breast Cancer CrossRef